PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23084283-7 2013 Serum creatinine in high cre/hANP (+) got to decrease more than high cre/hANP (-). Creatinine 6-16 natriuretic peptide A Homo sapiens 29-33 23702231-8 2013 Serum creatinine and BNP were also significantly lower in the hANP group at 1 year postoperatively. Creatinine 6-16 natriuretic peptide A Homo sapiens 62-66 25748698-5 2015 Significant decreases in serum creatinine levels were observed by -14.0% +- 14.2% in the hANP + DA group compared with the hANP + furosemide group (4.5% +- 9.6%, P = 0.0011) without increases in the renotubular and myocardial markers. Creatinine 31-41 natriuretic peptide A Homo sapiens 89-93 23084283-7 2013 Serum creatinine in high cre/hANP (+) got to decrease more than high cre/hANP (-). Creatinine 6-16 natriuretic peptide A Homo sapiens 73-77 9205939-6 1997 The effect of atenolol on ANP positively correlated with duration of hypertension (r = 0.74), ECG score for LVH (r = 0.73) and serum creatinine (r = 0.68). Creatinine 133-143 natriuretic peptide A Homo sapiens 26-29 18431264-12 2008 The mean serum concentrations of creatinine and blood urea nitrogen were significantly (p < .05) lower in the hANP group than in the placebo group. Creatinine 33-43 natriuretic peptide A Homo sapiens 113-117 18431264-13 2008 The mean urine volume and mean creatinine clearance were significantly (p < .05) higher in the hANP group than in the placebo group. Creatinine 31-41 natriuretic peptide A Homo sapiens 98-102 18431264-14 2008 The mean urinary NAG/creatinine ratio was significantly (p < .05) lower in the hANP group than in the placebo group. Creatinine 21-31 natriuretic peptide A Homo sapiens 82-86 11350271-8 2001 In pre-dialysis patients, serum creatinine ranged from 110 to 447 microM L-1 and was significantly correlated to plasma N-terminal proANP (r = 0.60, P < 0.05) but not to ANP. Creatinine 32-42 natriuretic peptide A Homo sapiens 134-137 22032777-5 2011 The infusion of ANP or BNP increased the urine output and creatinine clearance or glomerular filtration rate, and reduced the use of diuretics and the serum creatinine levels. Creatinine 58-68 natriuretic peptide A Homo sapiens 16-19 22032777-5 2011 The infusion of ANP or BNP increased the urine output and creatinine clearance or glomerular filtration rate, and reduced the use of diuretics and the serum creatinine levels. Creatinine 157-167 natriuretic peptide A Homo sapiens 16-19 22032777-6 2011 A meta-analysis showed that ANP infusion significantly decreased peak serum creatinine levels, incidence of arrhythmia and renal replacement therapy. Creatinine 76-86 natriuretic peptide A Homo sapiens 28-31 20413036-8 2010 Serum creatinine was significantly lower in the hANP group than the placebo group at 1 month, 6 months, and 1 year post-operatively, whereas the estimated glomerular filtration rate was significantly higher in the hANP group at these times. Creatinine 6-16 natriuretic peptide A Homo sapiens 48-52 11903396-14 2001 CONCLUSIONS: Intravenous infusion of BNP and ANP both increase the urine excretion of albumin and the tubular protein alpha1 microglobulin, independent of creatinine clearance. Creatinine 155-165 natriuretic peptide A Homo sapiens 45-48 9205939-7 1997 Individual changes in ANP by zofenopril negatively correlated with pretreatment ANP (r = -0.69), ECG score for LVH (r = -0.44) and serum creatinine (r = -0.41). Creatinine 137-147 natriuretic peptide A Homo sapiens 22-25 1472664-4 1992 Preoperative plasma ANP did not correlate with hemodynamics, but was negatively correlated with creatinine clearance (r = -0.76, P < .01). Creatinine 96-106 natriuretic peptide A Homo sapiens 20-23 8333281-9 1993 The change of ANF levels was positively correlated with the body weight change and creatinine change after HD. Creatinine 83-93 natriuretic peptide A Homo sapiens 14-17 8358985-3 1993 In SLE patients, hANP levels correlated with serum creatinine concentration and the patients with proteinuria showed high levels of hANP. Creatinine 51-61 natriuretic peptide A Homo sapiens 17-21 1472664-7 1992 Postoperative plasma ANP was not correlated with hemodynamics, but was negatively correlated with both creatinine clearance (r = -0.65, P < .05) and content of ANP in the native atria (r = -0.75, P < .01). Creatinine 103-113 natriuretic peptide A Homo sapiens 21-24 1451221-7 1992 Creatinine clearance was increased by hANP infusion, but did not change in the nicardipine group. Creatinine 0-10 natriuretic peptide A Homo sapiens 38-42 1830872-5 1991 Per cent and absolute changes in plasma ANP level correlated significantly with concomitant changes in body weight (r = 0.764; p less than 0.001 and r = 0.558; p less than 0.01, resp.) but not with changes in serum creatinine, blood pressure or serum electrolytes. Creatinine 215-225 natriuretic peptide A Homo sapiens 40-43 2151149-1 1990 The aim of the study was the search for the correlation between the degree of impairment renal function (measured by creatinine clearance) and plasma concentration of atrial natriuretic peptide (ANP) and urinary fractional sodium excretion (FENa) in patients with chronic renal diseases. Creatinine 117-127 natriuretic peptide A Homo sapiens 167-193 2151149-1 1990 The aim of the study was the search for the correlation between the degree of impairment renal function (measured by creatinine clearance) and plasma concentration of atrial natriuretic peptide (ANP) and urinary fractional sodium excretion (FENa) in patients with chronic renal diseases. Creatinine 117-127 natriuretic peptide A Homo sapiens 195-198 2533973-5 1989 In healthy volunteers, however, the same dose of ANF increased urinary excretion of sodium, potassium, calcium, chloride and phosphorus as well as water, and creatinine clearances, and decreased plasma aldosterone. Creatinine 158-168 natriuretic peptide A Homo sapiens 49-52 2138254-9 1990 In these patients there was a highly significant correlation between serum creatinine and plasma ANP concentrations (p less than 0.01; r = 0.75; y = 0.2x + 3). Creatinine 75-85 natriuretic peptide A Homo sapiens 97-100 2527663-10 1989 Among the diabetic patients, ANF was directly related to HbA1 (r = 0.49, P less than 0.005) and urinary albumin excretion (r = 0.40, P less than 0.02), and was inversely related to PRA (r = 0.36, P less than 0.04) and plasma creatinine (r = -0.42, P less than 0.02). Creatinine 225-235 natriuretic peptide A Homo sapiens 29-32 2527765-8 1989 On the other hand, a positive correlation (r = 0.65, p less than 0.05) between alpha hANP and creatinine in blood was found only in the group of chronic renal failure before maintenance hemodialysis. Creatinine 94-104 natriuretic peptide A Homo sapiens 85-89 2473351-3 1989 In a multivariate analysis, plasma ANP was independently and positively related to age (p less than 0.001), urinary sodium excretion (p less than 0.01), and inversely related to creatinine clearance (p less than 0.02).These variables explained more than 12% of the variability of plasma levels of ANP. Creatinine 178-188 natriuretic peptide A Homo sapiens 35-38 2530666-6 1989 In the six patients with functioning grafts, ANF declined in parallel with the fall in serum creatinine (658 +/- 35 to 210 +/- 34 mumol/L). Creatinine 93-103 natriuretic peptide A Homo sapiens 45-48 2530666-8 1989 There was overall a significant linear relation between serum creatinine and plasma ANF (r = 0.527, P less than 0.001). Creatinine 62-72 natriuretic peptide A Homo sapiens 84-87 2795975-6 1989 The ANP level and the creatinine clearance showed significant negative correlation, indicating that one of the reasons for impaired renal function among aged patients could be the decreased ANP level in blood. Creatinine 22-32 natriuretic peptide A Homo sapiens 190-193 2523266-4 1989 Moreover, a negative correlation was found between plasma ANP levels and creatinine clearance. Creatinine 73-83 natriuretic peptide A Homo sapiens 58-61 2521490-5 1989 Renal plasma ANF clearance in human subjects was 78 +/- 12 ml/min per kidney and correlated well with each kidney"s creatinine clearance (r = 0.58, P less than 0.05). Creatinine 116-126 natriuretic peptide A Homo sapiens 13-16 2975995-4 1988 Atrial natriuretic factor caused a significant increase in sodium excretion (UNaV) [+56%], urinary flow rate (V) [+17%] and free water clearance (CH2O) [+23%]; creatinine clearance (Ccr) did not change. Creatinine 160-170 natriuretic peptide A Homo sapiens 0-25 2847885-3 1988 In the patients with renal parenchymal hypertension, plasma ANP correlated negatively with creatinine clearance (r = -0.76, p less than 0.001). Creatinine 91-101 natriuretic peptide A Homo sapiens 60-63 2970166-7 1988 In this subgroup, increased creatinine clearance tended to be found more frequently among patients with increased hANP levels. Creatinine 28-38 natriuretic peptide A Homo sapiens 114-118 2943055-5 1986 Plasma ANP level was conversely correlated with creatinine clearance (r = -0.812, p less than 0.001) in patients with renal diseases (n = 29). Creatinine 48-58 natriuretic peptide A Homo sapiens 7-10 2821056-10 1987 alpha hANP also increased urine volume [176 +/- 31 (+/- SEM) vs. 113 +/- 19 mL/mmol creatinine with placebo; P less than 0.03] and sodium excretion (2.14 +/- 0.48 vs. 0.58 +/- 0.22 mmol/mmol creatinine with placebo; P less than 0.004) on the ACTH infusion days. Creatinine 84-94 natriuretic peptide A Homo sapiens 6-10 2821056-10 1987 alpha hANP also increased urine volume [176 +/- 31 (+/- SEM) vs. 113 +/- 19 mL/mmol creatinine with placebo; P less than 0.03] and sodium excretion (2.14 +/- 0.48 vs. 0.58 +/- 0.22 mmol/mmol creatinine with placebo; P less than 0.004) on the ACTH infusion days. Creatinine 191-201 natriuretic peptide A Homo sapiens 6-10 2951044-3 1987 In 13 non-HD patients with serum creatinine values from 2.0 to 8.3 mg/dl, mean plasma hANP (+/- SE) was 404 +/- 23 pg/ml, while it was 236 +/- 11 pg/ml in the normal control group (n = 15) and the difference was significant (p less than 0.001). Creatinine 33-43 natriuretic peptide A Homo sapiens 86-90